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THE separation and purification of human islets from 
the pancreas of pediatric-age donors has been con-
sidered difficult if not impossible because of easy fragmen-
tation of the islets and/or their incomplete separation from 
the enclosing acinar tissue (embedding). I.:! The purpose of 
this study was to develop a method to separate and purify 
large numbers of viable human islets from pediatric do-
nors. After preliminary studies on swine islet isolation3 
which resemble pediatric human isolation in many ways, a 
modification of the automated method for adult human 
islet isolation was developed. 
MATERIALS AND METHODS 
Six pancreata obtained from pediatric donors 'age 7 to 18) were 
distended by intraductal injection of 200 to ~<;<g mL of Hanks' 
solution with I mglmL collagenase (Boehringer-Mannheim, Type 
P) and loaded into a digestion chamber (volume 450 mLl contain-
ing a stainless steel screen (400-J.LI11 pore size). and 7 solid glass 
marbles. I After a first phase of recirculation of the collagenase 
solution in a closed system (12 to 18') in .. ruch intrachamber 
temperature was progressively raised from ~ to 37°C (ftow 
rate: 50 mUmin). the islets were collected during a dilution phase 
of 15 to 30' (flow rate: 300 mUmin). Any mechanical trauma to the 
islets during separation was carefully avoided. ~ Final purification 
of the islets was obtained by discontinuous density gradient 
separation with Euro-Collins solution used as vehicle for the 
FicoH powder (Sigma. DL-4(0). Three layers (densities = 1108, 
1096. and 1037) have been used.· After centrifugation on a COBE 
2991 cell processor.s.1> the islets were retrieved from both 1.0371 
1.096 (purity 80% to 95%) and from 1.0961\.108 (purity 40% to 
50%) interfaces. Morphologic and functional integrity of the islet 
preparation have been assessed following ~ criteria recently 
proposed for islet isolation assessment. 7 The functional integrity 
of the final preparation was tested by transplantation of an aliquot 
of the final preparation into diabetic nude mice- and by aHotrans-
plantation in patients who underwent total paocreatectomy as part 
of an upper abdominal exenteration9 for malignancy. 
The main modifications from the procedure for adult human 
islet isolation I consisted in the absence of heating circuit bypass, 
the absence of a cooling circuit, the absence of shaking during the 
recirculation phase. the increased volume of the digestion cham-
ber. and the increased pore size of the stainless steel screen. 
RESULTS AND DISCUSSION 
The results of 6 consecutive pediatric islet isolations are 
summarized in Table I. An average of over 430,000 islets 
were obtained after the purification process, representing 
over 9500 islets per gram of pancreatic tissue. The purity of 
the final islet preparation ranged between 40% and 90% 
islets. Histologic studies showed that the islets obtained by 
this procedure were weU preserved. Significant basal and 
stimulated C-peptide production have been shown in all 
patients who received pediatric islet allografts. The results 
of clinical islet transplantation. described in detail 
elsewhere,lo demonstrated that this procedure resulted in 
numbers of viable pancreatic islets from a single pediatric 
donor sufficient to prevent pancreatectomy-induced diabe-
tes mellitus following intraportal islet allotransplantation. 
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Table 1. Donor Pancreas Data and Postpurtflcatlon Islet Isolation Results 
Donor Pancreas PosIpurifocallOn Islet Assess I oent 
Weight err Number' v'*- Purity 
No. Age (g) (h) (x 1(00) (lit.) 1SIeI;9 ('II. IsIeIS) 
18 48.2 8 47" 0.839 9834 60 
2 7 23.2 8 562 0.993 24.224 50 
3 18 108.0 7 105 0.186 972 70 
4 18 100.0 6 285 0.504 2850 40 
5 17 40.0 10 459 0.811 11.475 90 
6 16 90.0 6 717 1.2ffl 7967 70 
Mean 433.7 0.767 9553 63.3 
SO 195.4 0.345 7528 16.0 
'CIT = cold ischemia lime. 
tEstimated number of islets with an average diameter 01150 p.m. 
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The combination of the automated method for islet sepa-
ration together with a purification process that involves the 
COBE cell separator represents a further step toward 
complete automation of cadaveric pancreatic islet isolation 
and purification. 
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